China’s ASK Buys 5 Percent Stake In New Zealand’s Living Cell Tech
This article was originally published in PharmAsia News
Executive Summary
China's Jiangsu Aosaikang Pharmaceutical (ASK) bought a 5 percent stake in New Zealand's Living Cell Technologies